Ying‐Hao Shen

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0001-6476-0648

发表论文 100 篇 · 总被引 2430 次 · h-index 28

代表论文

• Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 40)
• Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies (2024 · International Immunopharmacology · 被引 19)
• The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy (2025 · Biomarker Research · 被引 15)
• CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils (2024 · Journal of Hepatocellular Carcinoma · 被引 15)
• CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance (2025 · Advanced Science · 被引 13)
• CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma (2025 · Cell Reports Medicine · 被引 10)